These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15288248)

  • 1. Using NMR for ligand discovery and optimization.
    Villar HO; Yan J; Hansen MR
    Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM
    Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided fragment screening for lead discovery.
    Verdonk ML; Hartshorn MJ
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragonomics: fragment-based drug discovery.
    Zartler ER; Shapiro MJ
    Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallography, NMR and virtual screening: integrated tools for drug discovery.
    Muchmore SW; Hajduk PJ
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):544-9. PubMed ID: 12951817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR fragment screening: tackling protein-protein interaction targets.
    Schade M; Oschkinat H
    Curr Opin Drug Discov Devel; 2005 May; 8(3):365-73. PubMed ID: 15892252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H; Cleasby A; Verdonk M; Williams G
    Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR fragment screening: Advantages and applications.
    Schade M
    IDrugs; 2006 Feb; 9(2):110-3. PubMed ID: 16523400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening in lead discovery and optimization.
    Jain AN
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based drug design: combining philosophy with technology.
    Bartoli S; Fincham CI; Fattori D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based lead discovery: leads by design.
    Carr RA; Congreve M; Murray CW; Rees DC
    Drug Discov Today; 2005 Jul; 10(14):987-92. PubMed ID: 16023057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of NMR-derived fragment leads in drug design.
    Huth JR; Sun C; Sauer DR; Hajduk PJ
    Methods Enzymol; 2005; 394():549-71. PubMed ID: 15808237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils.
    Middleton DA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):985-90. PubMed ID: 17956260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NMR-based screening of protein inhibitors in drug discovery].
    Hu HY
    Yao Xue Xue Bao; 2002 Feb; 37(2):158-60. PubMed ID: 12579966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.